News

Nava Health MD, Inc. and 99 Acquisition Group, Inc. Announce Merger Agreement for Nava Health To Become a Publicly Traded Entity

Nava Health MD, Inc. ("Nava Health") has entered into a definitive merger agreement with 99 Acquisition Group, Inc. (NASDAQ:NNAG)Nava Health…

4 months ago

The International Myeloma Foundation Launches the Iceland Cycling Expedition: A Fundraiser to Advance the Goals of the iStopMM Project and the IMF’s Robust Array of Research Initiatives

STUDIO CITY, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) is excited to announce the launch…

4 months ago

Palisade Bio Provides Corporate Update and Reiterates Guidance

– Company announces strategic streamlining of Board to align with the current state of clinical development and corporate vision –…

4 months ago

ICU Medical Announces Time of Fourth Quarter 2023 Earnings Conference Call

SAN CLEMENTE, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture…

4 months ago

Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing

JUPITER, Fla. and LELAND, N.C., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Dyadic International Inc. (“Dyadic”, or the “Company”) (Nasdaq: DYAI)…

4 months ago

RespireRx Pharmaceuticals Inc. Reports Preclinical Pain Relief for their Non-Opioid Lead GABAkine

Glen Rock, N.J., Feb. 13, 2024 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Pink Market: RSPI) (“RespireRx” or the “Company”),…

4 months ago

Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process

Company secures $22.5 million of new money in debtor-in-possession financing from existing lenders to support ongoing operations during the sale…

4 months ago

CRISPR Therapeutics Announces $280 Million Registered Direct Offering

- Led by new investor EcoR1 Capital and SR One with participation from existing and new investors - - Well positioned…

4 months ago

Wandercraft’s self-balancing exoskeleton receives second FDA clearance in less than a year, now indicated for rehabilitation in patients with spinal cord injury

Wandercraft's self-balancing exoskeleton receives second FDA clearance in less than a year, now indicated for rehabilitation in patients with spinal…

4 months ago

Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024

CAPE CANAVERAL, Fla., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of…

4 months ago